NCCN Guidelines® Insights - Breast Cancer, Version 3.2018
These NCCN Guidelines Insights highlight the updated recommendations for use of multigene assays to guide decisions on adjuvant systemic chemotherapy therapy for women with hormone receptor-positive, HER2-negative early-stage invasive breast cancer.
Category
  • Breast Cancer
Format
  • Monograph/Journal Supplement
Credits
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • AAPA Category 1 CME credit
  • Participation
Recorded Presentation from the NCCN 2018-2019 Oncology Case Manager and Medical Director Program: Integrating Palliative Care into the Oncology Care Continuum
Although there is general agreement on the importance and benefits of early integration of palliative care in oncology, timely and seamless integration remains a major challenge.
Category
  • Palliative Care
Format
  • Recorded Webcast
Credits
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • CCM clock hours
  • AAPA Category 1 CME credit
  • Participation
Recorded Presentation from the NCCN 2018-2019 Oncology Case Manager and Medical Director Program: Diagnosis and Management of Hematologic Malignancies
Case managers and medical directors need to be familiar with all the aspects of clinical management including diagnosis, prognostic stratification, treatment options, assessment of response to treatment, supportive care and survivorship care.
Category
  • Hematologic Malignancies
Format
  • Recorded Webcast
Credits
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • CCM clock hours
  • AAPA Category 1 CME credit
  • Participation
New Systemic Therapies for Metastatic Breast Cancer, Including SABCS Updates
This information was originally presented at the NCCN 2019 Congress Series™: Breast Cancer with Updates from the 2018 San Antonio Breast Cancer Symposium (SABCS) held in Chicago, Illinois, on February 8, 2019.
Category
  • Breast Cancer
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Management of Lymphedema after Breast Cancer Treatment
This information was originally presented at the NCCN 2019 Congress Series™: Breast Cancer with Updates from the 2018 San Antonio Breast Cancer Symposium (SABCS) held in Chicago, Illinois, on February 8, 2019.
Category
  • Breast Cancer
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Utility of Multigene Assays in Management of Early Stage Breast Cancer
This information was originally presented at the NCCN 2019 Congress Series™: Breast Cancer with Updates from the 2018 San Antonio Breast Cancer Symposium (SABCS) held in Chicago, Illinois, on February 8, 2019.
Category
  • Breast Cancer
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Genetic/Familial High-Risk Evaluation in Patients with Breast Cancer
Individuals found to have a hereditary breast cancer syndrome should be managed appropriately, with an emphasis on screening considerably earlier than standard recommendations.
Category
  • Breast Cancer
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Implementation and Implications of AJCC Cancer Staging Manual, 8th Edition for Breast Cancer Staging
With the release of the 8th edition of the AJCC staging manual,  it is important for clinicians to be aware of the updates to the AJCC TNM staging in order to select appropriate treatment, evaluate treatment outcomes, participate in clinical trials, and facilitate accurate information sharing amo
Category
  • Breast Cancer
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Evidence-Based Integrative Therapies in Breast Cancer
With the large number of patients and survivors already using non-conventional therapies, it is critical for oncology professionals to understand the importance of asking their patients about such modalities and to be knowledgeable enough to discuss the risks, benefits, and goals of non-conventio
Category
  • Breast Cancer
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Locoregional Treatment of Breast Cancer, Including SABCS Updates
Locoregional management strategies have considerably evolved.  Although several randomized studies have identified patients that do not need ALND, a recent survey revealed substantial variation in surgeon management suggesting the potential for overtreatment of many patients and the need for educ
Category
  • Breast Cancer
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation

Pages